Observed versus predicted mortality after mitraclip treatment in patients with symptomatic heart failure and significant functional mitral regurgitation

Back

ESC Premium Access

Observed versus predicted mortality after mitraclip treatment in patients with symptomatic heart failure and significant functional mitral regurgitation

Session: Devices and multidisciplinary interventions in heart failure

Topic: Prognosis

Speaker: Doctor A. Scotti (Bronx, US)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Andrea Scotti

Montefiore Medical Center, Bronx (United States of America)

0 follower

9 more presentations in this session

Distinct hemodynamic changes after interventional mitral valve edge to edge repair in different phenotypes of heart failure

Speaker: Doctor B. Schrage (Hamburg, DE)

Morbidity and mortality of chronic heart failure (CHF) patients with central sleep apnoea (CSA) treated by adaptive servoventilation (ASV): Interim results of FACE cohort study

Speaker: Professor J. Davy (Montpellier, FR)

Acute modifications of left ventricular torsional mechanics induced by cardiac resynchronization therapy affect short-term reverse remodelling

Speaker: Professor P. Marino (Novara, IT)

Two-year outcomes after mitraclip treatment of functional mitral regurgitation in ischemic and non-ischemic dilated cardiomyopathy.

Speaker: Doctor A. Scotti (Bronx, US)

The role of myocardial fibrosis in the recovery of left ventricular ejection fraction after TAVI

Speaker: Doctor A. Sedaghat (Bonn, DE)

Access the full session

Devices and multidisciplinary interventions in heart failure

Speakers: Doctor A. Scotti, Doctor B. Schrage, Professor J. Davy, Professor P. Marino, Doctor A. Scotti...

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources